Skip to content
RDL
Network
Ecosystem
Switch app
TR
About
FAQ
Sign in
Get started
Can glatiramer acetate reduce brain atrophy development in multiple sclerosis? — Marco Rovaris (2005) | RDL Network
Back
Cite
Save
Save for later
Share
Home
Publications
Can glatiramer acetate reduce brain atrophy development in multiple sclerosis?
Shared by
Massimo Filippi
Can glatiramer acetate reduce brain atrophy development in multiple sclerosis?
Article
2005
en
Authors
MR
Marco Rovaris
GC
Giancarlo Comi
Massimo Filippi
Discussion
(0)
Sign in
to like and join the discussion.
No comments yet. Be the first to comment.
Related publications
Article
2005
Glatiramer acetate in multiple sclerosis
Domenico Maria Mezzapesa
,
Marco Rovaris
,
Massimo Filippi
Article
2006
Glatiramer acetate therapy for multiple sclerosis: a review
Jai Perumal
,
Massimo Filippi
,
Corey C. Ford
,
Kenneth P. Johnson
,
Robert P. Lisak
,
Luanne M. Metz
,
Alexandros Tselis
,
Mark Tullman
,
Omar Khan
Article
2010
Phase III dose‐comparison study of glatiramer acetate for multiple sclerosis
Giancarlo Comi
,
Jeffrey A. Cohen
,
Douglas L. Arnold
,
Daniel Wynn
,
Massimo Filippi
Article
2005
The distribution of the magnetic resonance imaging response to glatiramer acetate in multiple sclerosis
Maria Pia Sormani
,
Paolo Bruzzi
,
Giancarlo Comi
,
Massimo Filippi
Article
2008
Can rate of brain atrophy in multiple sclerosis be explained by clinical and MRI characteristics?
T. Korteweg
,
Marco Rovaris
,
Veronica Neacsu
,
Massimo Filippi
,
Giancarlo Comi
,
Bernard M.J. Uitdehaag
,
DL Knol
,
CH Polman
,
Frederik Barkhof
,
Hugo Vrenken
Discussion(0)
No comments yet. Be the first to comment.